Intravenous tPA Therapy Does Not Worsen Acute Intracerebral Hemorrhage in Mice

Tissue plasminogen activator (tPA) is the only FDA-approved treatment for reperfusing ischemic strokes. But widespread use of tPA is still limited by fears of inadvertently administering tPA in patients with intracerebral hemorrhage (ICH). Surprisingly, however, the assumption that tPA will worsen I...

Descripción completa

Detalles Bibliográficos
Autores principales: Foerch, Christian, Rosidi, Nathanael L., Schlunk, Frieder, Lauer, Arne, Cianchetti, Flor A., Mandeville, Emiri, Arai, Ken, Yigitkanli, Kazim, Fan, Xiang, Wang, Xiaoying, van Leyen, Klaus, Steinmetz, Helmuth, Schaffer, Chris B., Lo, Eng H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568130/
https://www.ncbi.nlm.nih.gov/pubmed/23408937
http://dx.doi.org/10.1371/journal.pone.0054203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568130/
https://www.ncbi.nlm.nih.gov/pubmed/23408937
http://dx.doi.org/10.1371/journal.pone.0054203

Ejemplares similares